Immatics NV (IMTX)
9.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 12:49
Immatics Research and Development Expense (TTM) : 254.72M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 254.72M |
| March 31, 2026 | 233.28M |
| December 31, 2025 | 208.14M |
| September 30, 2025 | 195.00M |
| June 30, 2025 | 182.61M |
| March 31, 2025 | 169.40M |
| December 31, 2024 | 160.14M |
| September 30, 2024 | 151.28M |
| June 30, 2024 | 141.71M |
| March 31, 2024 | 133.53M |
| December 31, 2023 | 128.28M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 106.31M |
| March 31, 2022 | 103.97M |
| December 31, 2021 | 103.53M |
| September 30, 2021 | 102.14M |
| June 30, 2021 | 97.54M |
| March 31, 2021 | 91.22M |
| December 31, 2020 | 76.95M |
| September 30, 2020 | 65.52M |
| June 30, 2020 | 56.47M |
| March 31, 2020 | 49.24M |
| December 31, 2019 | 44.82M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| MediGene AG | -- |
| InflaRx NV | 25.38M |
| BioNTech SE | 2.414B |
| Moderna, Inc. | 2.635B |
| Intellia Therapeutics, Inc. | 337.63M |